DIS3L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.529900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.802400E-01
Normal-vs-Stage2
6.384300E-02
Normal-vs-Stage3
5.396700E-03
Normal-vs-Stage4
3.993800E-01
Stage1-vs-Stage2
3.440400E-02
Stage1-vs-Stage3
1.276300E-02
Stage1-vs-Stage4
4.052200E-01
Stage2-vs-Stage3
9.407500E-02
Stage2-vs-Stage4
7.247000E-01
Stage3-vs-Stage4
2.865600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.940000E-02
Normal-vs-AfricanAmerican
2.948600E-01
Normal-vs-Asian
8.599600E-02
Caucasian-vs-AfricanAmerican
5.676800E-01
Caucasian-vs-Asian
3.361800E-01
AfricanAmerican-vs-Asian
3.294800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.531700E-02
Normal-vs-Female
1.555850E-01
Male-vs-Female
1.247770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.557400E-01
Normal-vs-Age(41-60Yrs)
1.989240E-01
Normal-vs-Age(61-80Yrs)
6.950400E-02
Normal-vs-Age(81-100Yrs)
4.052300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.402200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.234800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.670010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.448190E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.806300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.047650E-02
Normal-vs-Daily Drinker
3.409900E-02
Normal-vs-Weekly Drinker
6.506100E-02
Normal-vs-Occasional Drinker
6.390300E-02
Normal-vs-Social Drinker
5.237400E-01
Non Drinker-vs-Daily Drinker
8.585200E-01
Non Drinker-vs-Weekly Drinker
8.144200E-01
Non Drinker-vs-Occasional Drinker
6.514200E-01
Non Drinker-vs-Social Drinker
9.832200E-02
Daily Drinker-vs-Weekly Drinker
7.464200E-01
Daily Drinker-vs-Occasional Drinker
6.064200E-01
Daily Drinker-vs-Social Drinker
6.933900E-02
Weekly Drinker-vs-Occasional Drinker
8.839800E-01
Weekly Drinker-vs-Social Drinker
1.823040E-01
Occasional Drinker-vs-Social Drinker
1.768440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.095200E-01
Normal-vs-Grade 2
8.133000E-01
Normal-vs-Grade 3
8.107600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.694200E-01
Grade 1-vs-Grade 3
3.832200E-01
Grade 1-vs-Grade 4
4.095200E-01
Grade 2-vs-Grade 3
9.585800E-01
Grade 2-vs-Grade 4
8.133000E-01
Grade 3-vs-Grade 4
8.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.869720E-02
Normal-vs-NonDiabetic
7.348400E-02
Diabetic-vs-NonDiabetic
1.479160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.313780E-01
Normal-vs-NoPancreatitis
5.698000E-02
Pancreatitis-vs-NoPancreatitis
6.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.734170E-01
Normal-vs-N1
6.807800E-02
N0-vs-N1
8.368600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.216000E-02
Normal-vs-TP53-NonMutant
5.363000E-01
TP53-Mutant-vs-TP53-NonMutant
4.644300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
